↓ Skip to main content

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Overview of attention for article published in Blood Advances, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
16 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model
Published in
Blood Advances, March 2019
DOI 10.1182/bloodadvances.2018025593
Pubmed ID
Authors

Chandini M Thirukkumaran, Zhong Qiao Shi, Gerard J Nuovo, Joanne Luider, Karen A Kopciuk, Yuan Dong, Ahmed A Mostafa, Satbir Thakur, Kathy Gratton, Ailian Yang, Alex C Chin, Matt C Coffey, Victor H Jimenez-Zepeda, Douglas Stewart, Marta Chesi, P Leif Bergsagel, Don Morris

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 19%
Researcher 7 17%
Student > Ph. D. Student 4 10%
Student > Doctoral Student 3 7%
Professor > Associate Professor 3 7%
Other 8 19%
Unknown 9 21%
Readers by discipline Count As %
Medicine and Dentistry 17 40%
Immunology and Microbiology 3 7%
Agricultural and Biological Sciences 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 3 7%
Unknown 12 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2020.
All research outputs
#3,626,778
of 23,133,982 outputs
Outputs from Blood Advances
#714
of 2,732 outputs
Outputs of similar age
#77,706
of 351,767 outputs
Outputs of similar age from Blood Advances
#35
of 117 outputs
Altmetric has tracked 23,133,982 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,732 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,767 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.